Clinical Trial Update: Ixabepilone + Carboplatin Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating ixabepilone in combination with carboplatin for metastatic breast cancer has completed, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Ixabepilone (ixabepilone)

Snippet

Sponsor: US Oncology Research | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-12-07